Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Sparing Strategies for Postoperative Nausea and Vomiting in Laparoscopic Cholecystectomy
ChiCTR2600120407Phase 4Recruiting
- Sponsor
- Taizhou Fourth People's Hospital
- Start
- Mar 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sufentanil and ketamine in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Taizhou Fourth People's Hospital. Primary endpoint: Incidence and severity of postoperative nausea and vomiting. Started Mar 2026; status: recruiting.
02
Drugs
sufentanilketamine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2600120407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120407.